Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance

Hypoxia-induced cisplatin resistance is a major challenge during non-small cell lung cancer (NSCLC) treatment. Based on previous studies, we further explored the effect of eukaryotic initiation factor 5A2 (eIF5A2) in hypoxia-induced cisplatin resistance. In this study, we found that autophagy and ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Guodong, Chen, Hang, Wu, Shibo, Chen, Jiabin, Zhang, Shufen, Shao, Guofeng, Sun, Lebo, Mu, Yinyu, Liu, Kaitai, Pan, Qiaoling, Li, Ni, An, Xiaoxia, Lin, Shuang, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356061/
https://www.ncbi.nlm.nih.gov/pubmed/35931669
http://dx.doi.org/10.1038/s41419-022-05033-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356061/
https://www.ncbi.nlm.nih.gov/pubmed/35931669
http://dx.doi.org/10.1038/s41419-022-05033-y

Ejemplares similares